EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudie

A Randomized, Controlled, Split-Face, Double-Blind Study Comparing Topical Malassezin to Hydroquinone 4% for Melasma

Pearl E Grimes, Shanaya Dias, Nicole Chizara Oparaugo, Tatiana Tatarinova, Tim McCraw

Journal of Drugs in Dermatology · 2026

DOI: 10.36849/jdd.9222 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Drugs in Dermatology, 2026. Verfasst von Pearl E Grimes und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Hydroquinones, Melanosis, Dermatologic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydroquinonesMelanosisDermatologic AgentsHumansFemaleDouble-Blind MethodAdultTreatment OutcomeMiddle AgedAdministration, CutaneousSeverity of Illness IndexYoung Adult

Substanzen

HydroquinoneshydroquinoneDermatologic Agents

Zitieren

APA

Grimes, P. E., Dias, S., Oparaugo, N. C., Tatarinova, T., & McCraw, T. (2026). A Randomized, Controlled, Split-Face, Double-Blind Study Comparing Topical Malassezin to Hydroquinone 4% for Melasma. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.9222

Vancouver

Grimes PE, Dias S, Oparaugo NC, Tatarinova T, McCraw T. A Randomized, Controlled, Split-Face, Double-Blind Study Comparing Topical Malassezin to Hydroquinone 4% for Melasma. Journal of Drugs in Dermatology. 2026. doi:10.36849/jdd.9222

BibTeX
@article{Grimes2026,
  author = {Grimes, Pearl E and Dias, Shanaya and Oparaugo, Nicole Chizara and Tatarinova, Tatiana and McCraw, Tim},
  title = {A Randomized, Controlled, Split-Face, Double-Blind Study Comparing Topical Malassezin to Hydroquinone 4% for Melasma},
  journal = {Journal of Drugs in Dermatology},
  year = {2026},
  doi = {10.36849/jdd.9222}
}
Kostenlos starten →